| HGNC Family | CD molecules (CD) |
| Name | membrane metallo-endopeptidase |
| Description | The protein encoded by this gene is a type II transmembrane glycoprotein and a common acute lymphocytic leukemia antigen that is an important cell surface marker in the diagnosis of human acute lymphocytic leukemia (ALL). The encoded protein is present on leukemic cells of pre-B phenotype, which represent 85% of cases of ALL. This protein is not restricted to leukemic cells, however, and is found on a variety of normal tissues. The protein is a neutral endopeptidase that cleaves peptides at the amino side of hydrophobic residues and inactivates several peptide hormones including glucagon, enkephalins, substance P, neurotensin, oxytocin, and bradykinin. [provided by RefSeq, Aug 2017] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMME, also known as neutral endopeptidase (NEP) or CD10, is a zinc‐dependent cell‐surface metallopeptidase with broad substrate specificity. It catalyzes the proteolytic cleavage of diverse bioactive peptides—including components of the renin–angiotensin system, where it converts angiotensin I into angiotensin (1–7) with vasodilatory and homeostatic effects—and its detailed three‐dimensional structure reveals the essential requirement for zinc binding in substrate recognition and catalysis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the brain, MME/NEP plays a critical role in peptide homeostasis by degrading amyloid‐β peptides. Multiple studies have demonstrated that reduced NEP activity or expression correlates with increased levels of amyloid‐β and the formation of pathogenic plaques in Alzheimer’s disease. Gene transfer strategies and hormonal regulation (for example, via estrogen receptors) have been shown to up‐regulate NEP and promote amyloid‐β clearance in vivo, thereby offering therapeutic promise by decreasing amyloid burden."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "4", "end_ref": "12"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMME also has important roles in renal and immunologic contexts. Aberrant expression or mutations in the MME gene have been implicated in immune‐mediated kidney disorders such as antenatal membranous glomerulonephritis, where NEP serves as a target antigen. Furthermore, in renal neoplasms the detection of CD10/NEP expression provides both prognostic and diagnostic value, and alterations in its levels have been linked to tumor aggressiveness in prostate and other cancers. In diabetic kidney disease, increased urinary NEP activity is thought to contribute to the local generation of protective peptides."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "13", "end_ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond these roles, MME exerts significant influence on the extracellular microenvironment in various tissues. In the mammary gland, its enzymatic activity helps regulate stem cell function by cleaving local signaling peptides, while in the skin it degrades neuropeptides such as substance P, thereby modulating inflammatory responses and wound healing. These multifaceted functions underscore the enzyme’s importance not only as a key mediator of physiological peptide catabolism but also as a valuable diagnostic and prognostic marker in several malignancies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "21", "end_ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Gillian I Rice, Daniel A Thomas, Peter J Grant, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20040634"}], "href": "https://doi.org/10.1042/BJ20040634"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15283675"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15283675"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Louis B Hersh, David W Rodgers "}, {"type": "b", "children": [{"type": "t", "text": "Neprilysin and amyloid beta peptide degradation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Alzheimer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/156720508783954703"}], "href": "https://doi.org/10.2174/156720508783954703"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18393807"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18393807"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "N N Nalivaeva, I A Zhuravin, A J Turner "}, {"type": "b", "children": [{"type": "t", "text": "Neprilysin expression and functions in development, ageing and disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mech Ageing Dev (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mad.2020.111363"}], "href": "https://doi.org/10.1016/j.mad.2020.111363"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32987038"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32987038"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Mélanie Carpentier, Yves Robitaille, Luc DesGroseillers, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neuropathol Exp Neurol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jnen/61.10.849"}], "href": "https://doi.org/10.1093/jnen/61.10.849"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12387451"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12387451"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Robert A Marr, Edward Rockenstein, Atish Mukherjee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neprilysin gene transfer reduces human amyloid pathology in transgenic mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2003)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12657655"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12657655"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Nobuhisa Iwata, Hiroaki Mizukami, Keiro Shirotani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.4792-03.2004"}], "href": "https://doi.org/10.1523/JNEUROSCI.4792-03.2004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14749444"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14749444"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Roberta Russo, Roberta Borghi, William Markesbery, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neprylisin decreases uniformly in Alzheimer's disease and in normal aging."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2005.09.054"}], "href": "https://doi.org/10.1016/j.febslet.2005.09.054"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16226260"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16226260"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Wesley Farris, Sonja G Schütz, John R Cirrito, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2353/ajpath.2007.070105"}], "href": "https://doi.org/10.2353/ajpath.2007.070105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17591969"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17591969"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Vicki Betts, Malcolm A Leissring, Georgia Dolios, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Dis (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nbd.2008.06.001"}], "href": "https://doi.org/10.1016/j.nbd.2008.06.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18602473"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18602473"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Nikolai D Belyaev, Natalia N Nalivaeva, Natalia Z Makova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO Rep (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/embor.2008.222"}], "href": "https://doi.org/10.1038/embor.2008.222"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19057576"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19057576"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "James Scott Miners, Shabnam Baig, Hannah Tayler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neuropathol Exp Neurol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/NEN.0b013e3181afe475"}], "href": "https://doi.org/10.1097/NEN.0b013e3181afe475"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19606063"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19606063"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Kaiwei Liang, Liuqing Yang, Chen Yin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Estrogen stimulates degradation of beta-amyloid peptide by up-regulating neprilysin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.051664"}], "href": "https://doi.org/10.1074/jbc.M109.051664"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19897485"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19897485"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Iman Osman, Herman Yee, Samir S Taneja, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neutral endopeptidase protein expression and prognosis in localized prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-04-0120"}], "href": "https://doi.org/10.1158/1078-0432.CCR-04-0120"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15217945"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15217945"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Hanna Debiec, Jeroen Nauta, Florence Coulet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lancet (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S0140-6736(04)17142-0"}], "href": "https://doi.org/10.1016/S0140-6736(04"}, {"type": "t", "text": "17142-0) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15464186"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15464186"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Peter R Mazal, Martin Stichenwirth, Anke Koller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mod Pathol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/modpathol.3800320"}], "href": "https://doi.org/10.1038/modpathol.3800320"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15502805"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15502805"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Marc A Dall'Era, Lawrence D True, Andrew F Siegel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential expression of CD10 in prostate cancer and its clinical implication."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Urol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2490-7-3"}], "href": "https://doi.org/10.1186/1471-2490-7-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17335564"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17335564"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Achim Fleischmann, Thorsten Schlomm, Hartwig Huland, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-08-1432"}], "href": "https://doi.org/10.1158/1078-0432.CCR-08-1432"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19047112"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19047112"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Verónica Berta Dorfman, Laura Pasquini, Miguel Riudavets, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Aging (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neurobiolaging.2008.09.016"}], "href": "https://doi.org/10.1016/j.neurobiolaging.2008.09.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19019493"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19019493"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Pierre Ronco, Hanna Debiec "}, {"type": "b", "children": [{"type": "t", "text": "Pathogenesis of membranous nephropathy: recent advances and future challenges."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Rev Nephrol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nrneph.2012.35"}], "href": "https://doi.org/10.1038/nrneph.2012.35"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22371247"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22371247"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Sridevi Gutta, Nadja Grobe, Meenasri Kumbaji, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased urinary angiotensin converting enzyme 2 and neprilysin in patients with type 2 diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Renal Physiol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajprenal.00565.2017"}], "href": "https://doi.org/10.1152/ajprenal.00565.2017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29561187"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29561187"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Keiichi Iwaya, Hitoshi Ogawa, Miki Izumi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Virchows Arch (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00428-002-0639-4"}], "href": "https://doi.org/10.1007/s00428-002-0639-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12070597"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12070597"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "MarcosA Antezana, Stephen R Sullivan, MarciaL Usui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neutral endopeptidase activity is increased in the skin of subjects with diabetic ulcers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1046/j.1523-1747.2002.19618.x"}], "href": "https://doi.org/10.1046/j.1523-1747.2002.19618.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12485446"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12485446"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Veronique Maguer-Satta, Roger Besançon, Elodie Bachelard-Cascales "}, {"type": "b", "children": [{"type": "t", "text": "Concise review: neutral endopeptidase (CD10): a multifaceted environment actor in stem cells, physiological mechanisms, and cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Stem Cells (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/stem.592"}], "href": "https://doi.org/10.1002/stem.592"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21425402"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21425402"}]}]}]}
|
| Synonyms | SCA43, CD10, CALLA, SFE |
| Proteins | NEP_HUMAN |
| NCBI Gene ID | 4311 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MME has 12,843 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 109 datasets.
Click the + buttons to view associations for MME from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of MME gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of MME gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of MME gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of MME gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of MME gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MME gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MME gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MME gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of MME gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with MME protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with MME gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MME gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MME gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of MME gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MME gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing MME protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with MME protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MME gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with MME gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with MME gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with MME gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by MME gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving MME gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with MME gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with MME gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with MME gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with MME gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for MME protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MME gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MME gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MME gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing MME from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with MME gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with MME gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of MME gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MME gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MME from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of MME gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MME gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of MME gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MME gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of MME gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of MME gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding MME protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving MME gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving MME gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing MME protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing MME protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by MME gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by MME gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MME gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of MME gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MME gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding MME receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with MME gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with MME gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of MME gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for MME protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of MME gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of MME gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of MME protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MME gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for MME from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP ASCT+B Annotations | cell types associated with MME gene from the HuBMAP ASCT+B dataset. | |
| HuBMAP ASCT+B Augmented with RNA-seq Coexpression | cell types associated with MME gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with MME gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with MME gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by MME gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for MME protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MME gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate MME protein from the curated KEA Substrates of Kinases dataset. | |
| KEGG Pathways | pathways involving MME protein from the KEGG Pathways dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MME gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with MME gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of MME gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of MME gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of MME gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MME gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing MME protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain MME protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MME gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting MME gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MME gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of MME gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by MME gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of MME gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with MME gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for MME from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MME gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of MME gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving MME protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving MME protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with MME protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate MME protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| Reactome Pathways 2014 | pathways involving MME protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving MME protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MME gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MME gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of MME gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of MME gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with MME protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of MME gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of MME gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of MME gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of MME protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of MME protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with MME protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| WikiPathways Pathways 2014 | pathways involving MME protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving MME protein from the WikiPathways Pathways 2024 dataset. | |